Reed John C (CIK 0001181561)

Latest company ownership

JNJ - JOHNSON & JOHNSON

Role: EVP, Innovative Medicine, R&D

Shares held

21,721

Last filed at

Oct 20, 2025

Confidence Score

17.7

2025Q4

Confidence Score History

2024Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 17, 2025	Oct 20, 2025	JOHNSON & JOHNSON	EVP, Innovative Medicine, R&D	Sell	17.5	-21,721	-67.08%	✗	$4.2M
Jul 17, 2025	Jul 18, 2025	JOHNSON & JOHNSON	EVP, Innovative Medicine, R&D	Sell	17.5	-19,137	-64.23%	✗	$3.1M
May 1, 2025	May 5, 2025	JOHNSON & JOHNSON	EVP, Innovative Medicine, R&D	Sell	17.5	-11,002	-26.97%	✗	$1.7M
Feb 15, 2025	Feb 18, 2025	JOHNSON & JOHNSON	EVP, Innovative Medicine, R&D	Sell	22.5	-385	-2.42%	✗	$60.1K
May 1, 2024	Oct 31, 2024	JOHNSON & JOHNSON	EVP, Innovative Medicine, R&D	Sell	17.5	-10,984	-42.97%	✗	$1.6M
May 1, 2024	May 3, 2024	JOHNSON & JOHNSON	EVP, Innovative Medicine, R&D	Sell	17.5	-10,984	-48.69%	✗	$1.6M